Calviks AB (publ) (STO:CALVIK)
Sweden · Delayed Price · Currency is SEK 30.10
-1.70 (-5.35%)
At close: Aug 1, 2025
Intra-Cellular Therapies Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2020 |
| 456.94 | 406.91 | 73.78 | 42.25 | 25.75 | 15.07 | Upgrade | |
Revenue Growth (YoY) | 265.12% | 451.55% | 74.61% | 64.05% | 70.94% | - | Upgrade |
Cost of Revenue | 413.77 | 363.22 | 59.84 | 23.94 | 12.14 | 7.27 | Upgrade |
Gross Profit | 43.17 | 43.68 | 13.93 | 18.31 | 13.61 | 7.8 | Upgrade |
Selling, General & Admin | 20.78 | 20.13 | 8.38 | 7.15 | 4.88 | 3.74 | Upgrade |
Other Operating Expenses | -0.91 | -1.66 | -1.33 | - | -0.03 | 0.01 | Upgrade |
Operating Expenses | 24.85 | 23.1 | 9.71 | 8.74 | 4.91 | 3.8 | Upgrade |
Operating Income | 18.32 | 20.58 | 4.22 | 9.57 | 8.7 | 4 | Upgrade |
Interest Expense | -4.35 | -4.04 | -1.54 | -0.33 | -0.01 | -0 | Upgrade |
Interest & Investment Income | 0.96 | 0.95 | 0.06 | - | - | - | Upgrade |
Earnings From Equity Investments | - | - | 0.01 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.04 | 0 | - | - | Upgrade |
Other Non Operating Income (Expenses) | 0 | 0 | -0.01 | - | 0 | - | Upgrade |
EBT Excluding Unusual Items | 14.94 | 17.51 | 2.79 | 9.25 | 8.69 | 4 | Upgrade |
Merger & Restructuring Charges | -0.49 | -0.49 | -0.37 | - | - | - | Upgrade |
Pretax Income | 14.45 | 17.02 | 2.43 | 9.25 | 8.69 | 4 | Upgrade |
Income Tax Expense | 4.2 | 4.28 | 0.91 | 2.15 | 1.94 | 0.88 | Upgrade |
Earnings From Continuing Operations | 10.25 | 12.73 | 1.51 | 7.1 | 6.75 | 3.12 | Upgrade |
Minority Interest in Earnings | -0.48 | -0.17 | - | - | -0.68 | - | Upgrade |
Net Income | 9.77 | 12.56 | 1.51 | 7.1 | 6.07 | 3.12 | Upgrade |
Net Income to Common | 9.77 | 12.56 | 1.51 | 7.1 | 6.07 | 3.12 | Upgrade |
Net Income Growth | 164.91% | 730.34% | -78.68% | 16.93% | 94.30% | -57.93% | Upgrade |
Shares Outstanding (Basic) | 5 | 5 | 4 | 3 | 3 | - | Upgrade |
Shares Outstanding (Diluted) | 5 | 5 | 4 | 3 | 3 | - | Upgrade |
Shares Change (YoY) | 24.39% | 30.53% | 9.30% | 13.22% | - | - | Upgrade |
EPS (Basic) | 1.98 | 2.59 | 0.41 | 2.09 | 2.02 | - | Upgrade |
EPS (Diluted) | 1.98 | 2.59 | 0.41 | 2.09 | 2.02 | - | Upgrade |
EPS Growth | 112.97% | 536.12% | -80.50% | 3.28% | - | - | Upgrade |
Free Cash Flow | 23.96 | 17.61 | 4.28 | 8.12 | 7.58 | 1.16 | Upgrade |
Free Cash Flow Per Share | 4.85 | 3.63 | 1.15 | 2.39 | 2.52 | - | Upgrade |
Dividend Per Share | - | - | - | 1.657 | - | - | Upgrade |
Gross Margin | 9.45% | 10.74% | 18.88% | 43.34% | 52.85% | 51.77% | Upgrade |
Operating Margin | 4.01% | 5.06% | 5.72% | 22.65% | 33.80% | 26.57% | Upgrade |
Profit Margin | 2.14% | 3.09% | 2.05% | 16.80% | 23.57% | 20.74% | Upgrade |
Free Cash Flow Margin | 5.24% | 4.33% | 5.79% | 19.22% | 29.43% | 7.71% | Upgrade |
EBITDA | 18.71 | 20.63 | 4.26 | 9.62 | 8.76 | 4.05 | Upgrade |
EBITDA Margin | 4.09% | 5.07% | 5.77% | 22.77% | 34.01% | 26.89% | Upgrade |
D&A For EBITDA | 0.39 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | Upgrade |
EBIT | 18.32 | 20.58 | 4.22 | 9.57 | 8.7 | 4 | Upgrade |
EBIT Margin | 4.01% | 5.06% | 5.72% | 22.65% | 33.80% | 26.57% | Upgrade |
Effective Tax Rate | 29.06% | 25.17% | 37.61% | 23.23% | 22.30% | 21.93% | Upgrade |
Revenue as Reported | - | - | - | - | 25.79 | 15.09 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.